Plain-English translation of NCT05159349 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Schizophrenia research guide →This is a long-term research study that will follow 1,200 people who were recently diagnosed with schizophrenia. Researchers want to understand how schizophrenia develops and changes throughout a person's life, and what signs might predict whether someone will experience a relapse or other challenges. The study will collect health information, biological samples, and use imaging and other tools to build a detailed picture of schizophrenia over time.
Most schizophrenia research is short-term, but we don't know enough about what happens to people over many years. This medication study aims to fill that gap by following patients from diagnosis forward, so researchers can discover which early signs predict who will struggle most and how to help them better.
You likely qualify if…
You likely don't qualify if…
You would become part of a long-term study where researchers follow your health over time. This involves regular check-ins in your community, health exams, providing biological samples (like blood), completing assessment scales, and sharing information about your symptoms and life. The study tracks you from the time you're first diagnosed to see how things change, what helps, and what challenges emerge.
AI-generated summary from trial data · Jun 20, 2026 · Not medical advice
China
Sponsor
Shanghai Mental Health Center
Collaborators
Fudan University
Enrollment target
~1,200 participants
Started
December 2021
Primary completion
November 2027
Age range
18 Years – 65 Years
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Weibo Zhang
Shanghai Mental Health Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.